Recent therapeutic advances in hemophilia have led to a wave of new FDA-approved agents, and with it concerns of growing costs for managing the disease. In light of increasing specialty spend in this category, health plans are beginning to consider identifying opportunities to implement care optimization and cost management strategies. AMCP convened an expert forum of stakeholders representing hemophilia treatment centers, specialty pharmacies, advocacy, clinicians, and health plans to discuss the current patient care and business models in delivering care to members with hemophilia in an effort to identify areas for more efficient care delivery. This report summarizes the key
considerations of the participating stakeholders.
On December 14-15, 2017, 13 clinicians and executives representing health plans, integrated delivery systems, pharmacy benefit managers, and employers convened in Arlington, Virginia as part of the Academy of Managed Care Pharmacy (AMCP) Market Insights Summit on the management of psoriasis. The treatment of patients with psoriasis presents numerous
challenges to managed care organizations. This report summarizes the key
considerations of the participating stakeholders.
The Academy of Managed Care Pharmacy (AMCP) held a Partnership Forum Driving Value and Outcomes in Oncology on Nov. 14 and 15 outside of Washington, D.C. More than 30 experts from across the country discussed topics such as the importance of greater cost transparency for patients, and the need for new quality and value measures. The November Partnership Forum, AMCP’s second event focusing on value in oncology, builds on results of last year’s forum as well as recent research on gaps in measuring outcomes in oncology care and new cancer medicines. AMCP will use the results of this event to inform future strategic initiatives and advocacy efforts. The proceedings document was published in the June 2018 issue of the Journal of Managed Care & Specialty Pharmacy.
The AMCP Partnership Forum, Advancing Value-Based Contracting, which took place on June 20-21, 2017, gathered national and regional health care leaders representing health plans, integrated delivery systems, pharmacy benefit managers, data and analytics experts, and biopharmaceutical companies to reach an important consensus on addressing the operational, legal and regulatory changes needed to fully leverage this new payment system for health care. The proceedings document was published in the October 2017 issue of the Journal of Managed Care & Specialty Pharmacy.
On January 26-27, 2017, AMCP co-sponsored a conference with the PhRMA Foundation on the use of CER and PCOR by patients, clinicians, and payers. The conference centered on existing strategies to enhance uptake and use of CER/PCOR, as well as the needs and gaps in the uptake and use of CER/PCOR evidence. The recommendations developed during the conference are anticipated to be published in the Journal of Managed Care & Specialty Pharmacy as a supplement over the summer in 2017.
The AMCP Partnership Forum, Driving Value and Outcomes in Oncology, which took place on November 15-16, 2016, gathered thought leaders to focus on the need to drive better value and outcomes in oncology for patients, providers, payers and delivery networks. Attendees discussed ideas and concepts to help sort through a wave of new oncology products coming to market each year. The proceedings document was published in the May 2017 issue of the Journal of Managed Care & Specialty Pharmacy.
The AMCP Partnership Forum, Enabling the Exchange of Clinical and Economic Data Pre-FDA Approval, which took place on September 13-14, 2016, gathered a diverse group of health care stakeholders representing managed care, the pharmaceutical industry, academia, providers, patients and others to develop recommendations for biopharmaceutical companies and health care decision makers to more easily communicate information on products awaiting Food and Drug Administration (FDA) approval. The proceedings document was published in the January 2017 issue of the Journal of Managed Care & Specialty Pharmacy.
The AMCP Partnership Forum, Navigating Innovations in Diabetes Care, which took place on July 19-20, 2016, gathered national health care decision-makers to focus on innovations in diabetes care that are producing changes to treatment options, patient engagement, accountability and patient-provider interactions. The proceedings document was published in the December 2016 issue of the Journal of Managed Care & Specialty Pharmacy.
The AMCP Partnership Forum, FDAMA 114: Improving the Exchange of Pharmacoeconomic Data, which took place on March 1-2, 2016, gathered a diverse group of health care stakeholders representing pharmaceutical companies, managed care organizations, academia, health care providers and patient advocacy groups to develop consensus on a wide range of recommendations to make it easier for pharmaceutical companies to share pharmacoeconomic information with health care organizations that make coverage decisions. The proceedings document was published in the July 2016 issue of the Journal of Managed Care & Specialty Pharmacy.
The Fifth Annual AMCP Foundation Symposium convened experts from the public and private sector on October 26, 2015, prior to AMCP Nexus 2015 in Orlando, FL, on innovative ways to take on the chronic disease challenge through prevention.
On September 16, 2015, AMCP hosted an Employee Health Benefits Executive Forum, which brought together 50 top executives from large U.S. companies and health plans across the nation for a full day of dialogue on critical issues facing the health care system.
The AMCP Partnership Forum, Driving New Advances in Dyslipidemia Management, which took place on September 16, 2015, gathered executives from health plans, pharmacy benefit management companies, community and specialty pharmacies and medical societies. The proceedings document was published in the April 2016 issue of the Journal of Managed Care & Specialty Pharmacy.
The AMCP Partnership Forum, Biosimilars - Ready, Set, Launch, which took place on June 10-11, 2015, convened a meeting of multiple stakeholders to address current readiness of MCOs to optimize biosimilars; identify gaps, challenges, and opportunities with regard to biosimilars; and recommend education and training content to help AMCP best meet the needs of its members and stakeholders. The proceedings document was published in the April 2016 issue of the Journal of Managed Care & Specialty Pharmacy.
On December 2, 2014, AMCP hosted its first-ever AMCP Health Plan Executive Forum, bringing together 60 health care executives from across the nation for a full day of dialogue on critical issues facing the health care system.
The Specialty Pharmacy and Patient Care: Are We at a Tipping Point? symposium was conducted on October 6, 2014, prior to AMCP Nexus 2014 in Boston, MA. The symposium examined the fundamental issues of access and affordability to specialty medicine and brought together payers, academics, and members of the pharmaceutical industry.
The AMCP Partnership Forum, Breaking the Link Between Pain Management and Opioid Use Disorder, took place on September 9, 2014, gathered multiple stakeholders to recommend activities and programs that AMCP can promote to improve pain management, prevent opioid use disorder (OUD), and improve medication assisted treatment outcomes. The proceedings document was published in the December 2015 issue of the Journal of Managed Care & Specialty Pharmacy.
The AMCP Partnership Forum, NCPDP Electronic Prior Authorization Standards - Building a Managed Care Implementation Plan, took place on April 23, 2014, gathered key stakeholders to explore how to support the process of implementing the new standard transactions for e-PA and to recommend activities and programs that AMCP can promote to speed the adoption of e-PA. This Partnership Forum included individuals from managed care organizations, the pharmaceutical industry, pharmacy benefit managers, electronic prescription hubs or networks, and health information technology vendors. The proceedings document was published in the July 2015 issue of the Journal of Managed Care & Specialty Pharmacy.
The Managed Care Integrated Care Summit on Epilepsy was held on October 15, 2013. The meeting report summarizes the unmeet needs of the epilepsy population and current perspectives and includes insights, comments, and recommendations by presenters and panelists who devoted their time and efforts to reconsider this puzzling disorder and how managed care organizations can improve both public health and individual patient outcomes.
The AMCP Partnership Forum, Electronic Solutions to Medication Reconciliation and Improving Transitions of Care, took place in June 2013, to explore how managed care pharmacy departments can work with their medication therapy management (MTM), ACO, community, and hospital pharmacists to collaborate in redesigning the Medication Reconciliation (MedRec) process for transitions of care. The Partnership Forum focused on electronic solutions to the MedRec process at admission and discharge, including the provision of key clinical assessment data. The proceedings document was published in the September 2014 issue of the Journal of Managed Care & Specialty Pharmacy.
|